Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
0001005201-19-000105
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2019-08-20 16:11:37
Reporting Period:
2019-08-12
Accepted Time:
2019-08-20 16:11:37
Original Submission Date:
2019-08-12
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1005201 Assertio Therapeutics Inc ASRT Pharmaceutical Preparations (2834) 943229046
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1758376 A. Daniel Peisert Assertio Therapeutics, Inc.
100 South Saunders Road, Suite 300
Lake Forest IL 60045
Svp And Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-08-12 2,900 $1.54 24,256 No 4 P Direct
Common Stock Acquisiton 2019-08-12 17,100 $1.57 41,356 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
Footnotes
  1. This amended Form 4 is being filed to correct the number of shares of common stock purchased by the reporting person on August 12, 2019. As a result of this correction, the total number of securities beneficially owned following the reported transactions changed as well.